Tuesday, June 28, 2022

Mid-market investor in advanced discussions to make offer for Burton pharma firm

Clinigen, the Burton-based pharmaceutical products and services company, has received a non-binding indicative proposal from Triton Investment Management Limited for a possible offer for the entire issued and to be issued ordinary share capital of the business.

The board of Clinigen said it is in advanced discussions with Triton regarding the proposal, but there can be no certainty that any firm offer will be made for the company, nor as to the terms on which any firm offer might be made.

Triton is an investment firm focused on mid-market businesses. They sit within one of four sectors: industrial tech, services, consumer and healthcare.

Triton is required, by no later than 30 December, to announce a firm intention to make an offer for Clinigen or that it does not intend to make an offer.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £33.60 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.

Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.